| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT00873197 | Healthy | Drug: granisetron | Prostrakan Pharmaceuticals | Phase 1 | 2009-04-01 | 2009-05-01 |
| NCT00868764 | Pharmacokinetics | Drug: granisetron | Prostrakan Pharmaceuticals | Phase 1 | 2009-04-01 | 2009-10-05 |
| NCT02457195 | Postoperative Nausea and Vomiting | Drug: granisetron | Milton S. Hershey Medical Center | Phase 2 | 2016-02-01 | 2016-09-12 |
| NCT00450853 | Vomiting | Drug: granisetron | Clinica Universidad de Navarra, Universidad de Navarra | Phase 2 | 2005-04-01 | 2015-01-26 |
| NCT01073696 | Healthy | Drug: granisetron IV|Drug: granisetron patch | Prostrakan Pharmaceuticals | Phase 1 | 2010-03-01 | 2010-09-24 |
| NCT00954291 | Cancer|Vomiting | | Taipei Medical University WanFang Hospital | | 2009-07-01 | 2010-09-03 |
| NCT02230371 | Myofascial Pain|Temporomandibular Disorders | Drug: Granisetron|Drug: Control (placebo) | Karolinska Institutet|Folktandvrden Stockholms ln AB | Phase 4 | 2007-03-01 | 2015-09-03 |
| NCT01352130 | Prolonged QTc Interval | Drug: Ondansetron|Drug: Granisetron | Tata Memorial Hospital | Phase 4 | 2007-03-01 | 2011-05-10 |
| NCT00890565 | Healthy | Drug: granisetron | Prostrakan Pharmaceuticals | Phase 1 | 2009-05-01 | 2010-09-24 |
| NCT03091881 | Spinal-induced Hypotension | Drug: Granisetron | Suez Canal University | Phase 4 | 2017-05-01 | 2017-03-21 |
| NCT01952886 | Malignant Glioma | Drug: Granisetron|Drug: Ondansetron | Duke University|Prostrakan Pharmaceuticals | Phase 2 | null | 2014-09-19 |
| NCT01989221 | Gastroparesis | Drug: Sancuso | Temple University | Phase 3 | 2012-11-01 | 2015-05-11 |
| NCT00834522 | Healthy | Drug: Granisetron hydrochloride 1 mg tablets|Drug: Kytril 1 mg tablets | Teva Pharmaceuticals USA | Phase 1 | 2005-07-01 | 2009-09-01 |
| NCT00231478 | Post-Operative Nausea and Vomiting | Drug: granisetron|Drug: granisetron | Hoffmann-La Roche | Phase 4 | 2007-04-01 | 2011-05-16 |
| NCT00834717 | Healthy | Drug: Granisetron hydrochloride 1 mg tablets|Drug: Kytril 1 mg tablets | Teva Pharmaceuticals USA | Phase 1 | 2005-09-01 | 2009-09-01 |
| NCT01662687 | Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV) | Drug: Sancuso patch|Drug: Kytril inj.+Kytril tab. | LG Life Sciences | Phase 4 | 2012-02-01 | 2012-08-15 |
| NCT01649258 | Breast Cancer|Nausea|Vomiting | Drug: granisetron transdermal system|Drug: fosaprepitant dimeglumine|Other: laboratory biomarker analysis | University of Southern California|National Cancer Institute (NCI) | | 2012-09-01 | 2015-06-22 |
| NCT01596400 | Chemotherapy Induced Nausea and Vomiting | Drug: granisetron transdermal system|Drug: Granisetron IV | Kyowa Kirin Pharmaceutical Development Ltd | Phase 1 | 2012-05-01 | 2017-03-01 |
| NCT01536392 | Cancer of the Cervix | Drug: Granisetron|Drug: Ondansetron|Behavioral: Questionnaires|Behavioral: Study Drug Diary | M.D. Anderson Cancer Center|Sancuso | Phase 3 | 2012-03-01 | 2016-06-22 |
| NCT01183481 | Nausea|Vomiting | Drug: Aprepitant|Radiation: Palliative radiation therapy|Drug: Granisetron | Sunnybrook Health Sciences Centre|Merck Frosst Canada Ltd. | Phase 2 | 2011-01-01 | 2014-11-17 |
| NCT01596426 | Chemotherapy Induced Nausea and Vomiting | Drug: Sancuso|Drug: IV granisetron | Kyowa Kirin Pharmaceutical Development Ltd | Phase 1 | 2018-07-01 | 2017-03-01 |
| NCT01659775 | Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV) | Drug: Sancuso patch|Drug: Zofran inj.+Zofran tab. | LG Life Sciences | Phase 4 | 2011-08-01 | 2013-07-23 |
